Interaction with alcohol is unknown. Please consult your doctor.

Combihale FT 12 mcg/18 mcg Redicaps may be unsafe to use during pregnancy.Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.

Combihale FT 12 mcg/18 mcg Redicaps is probably safe to use during lactation. Limited human data suggests that the drug does not represent a significant risk to the baby.Monitor the baby for dry mouth, constipation, and urinary problems.

Combihale FT 12 mcg/18 mcg Redicaps may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.

Combihale FT 12 mcg/18 mcg Redicaps is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Combihale FT 12 mcg/18 mcg Redicaps may not be needed in these patients. Please consult your doctor.

There is limited information available on the use of Combihale FT 12 mcg/18 mcg Redicaps in patients with liver disease. Please consult your doctor.